We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$250M
AUM Growth
-$3.21M
Cap. Flow
-$9.77M
Cap. Flow %
-3.9%
Top 10 Hldgs %
39.19%
Holding
61
New
2
Increased
2
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$2.26M
2
XLNX
Xilinx Inc
XLNX
+$1.81M
3
ADI icon
Analog Devices
ADI
+$1.76M
4
NYT icon
New York Times
NYT
+$1.65M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.97M
2
WBA
Walgreens Boots Alliance
WBA
+$2.68M
3
PG icon
Procter & Gamble
PG
+$2.53M
4
IPGP icon
IPG Photonics
IPGP
+$1.81M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.47M

Sector Composition

Rank Sector Weight
1 Healthcare 26.32%
2 Industrials 19.26%
3 Technology 18.3%
4 Communication Services 9.29%
5 Financials 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$609B
$15.4M 6.17%
127,231
– –
AAPL icon
2
Apple
AAPL
$4.9T
$13.7M 5.48%
296,140
– –
MA icon
3
Mastercard
MA
$480B
$11.1M 4.45%
56,640
– –
PYPL icon
4
PayPal
PYPL
$49.9B
$11.1M 4.42%
132,850
– –
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.23T
$8.93M 3.57%
158,100
-17,000
-10% -$925K
NSC icon
6
Norfolk Southern
NSC
$76.4B
$8.48M 3.39%
56,185
– –
IPGP icon
7
IPG Photonics
IPGP
$4.43B
$7.96M 3.18%
36,090
-7,670
-18% -$1.81M
ADI icon
8
Analog Devices
ADI
$183B
$7.41M 2.96%
77,270
+18,670
+32% +$1.76M
ROK icon
9
Rockwell Automation
ROK
$51.4B
$6.99M 2.8%
42,070
– –
WM icon
10
Waste Management
WM
$96.1B
$6.96M 2.78%
85,625
– –
XYL icon
11
Xylem
XYL
$29.2B
$6.31M 2.52%
93,625
– –
DHR icon
12
Danaher
DHR
$144B
$6.2M 2.48%
70,900
– –
DIS icon
13
Walt Disney
DIS
$170B
$6.14M 2.46%
58,625
– –
ATR icon
14
AptarGroup
ATR
$8.46B
$6.1M 2.44%
65,275
– –
GE icon
15
GE Aerospace
GE
$364B
$5.84M 2.34%
89,578
– –
XLNX
16
DELISTED
Xilinx Inc
XLNX
$5.83M 2.33%
89,290
+26,540
+42% +$1.81M
ADP icon
17
Automatic Data Processing
ADP
$102B
$5.58M 2.23%
41,590
– –
MMM icon
18
3M
MMM
$83.4B
$5.51M 2.2%
33,488
– –
BSX icon
19
Boston Scientific
BSX
$65.4B
$5.43M 2.17%
166,015
– –
NKE icon
20
Nike
NKE
$64.9B
$5.43M 2.17%
68,110
– –
PG icon
21
Procter & Gamble
PG
$349B
$5.07M 2.03%
65,000
-33,635
-34% -$2.53M
HD icon
22
Home Depot
HD
$338B
$4.68M 1.87%
24,000
– –
XOM icon
23
ExxonMobil
XOM
$611B
$4.68M 1.87%
56,540
-10,000
-15% -$797K
ABT icon
24
Abbott
ABT
$175B
$4.63M 1.85%
75,850
– –
MRK icon
25
Merck
MRK
$315B
$4.58M 1.83%
79,098
– –
1
2 3

Similar funds

RC
RBO & Co Saint Helena, California $620M AUM 4.67% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $620M AUM 16.24% 1-Year Est. Return
KFAS
Keating Financial Advisory Services Manhattan, Kansas $619M AUM
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
RIS
Richmond Investment Services Mequon, Wisconsin $619M AUM 22.39% 1-Year Est. Return
AMG
Asset Management Group Stamford, Connecticut $619M AUM 15.97% 1-Year Est. Return
BWP
Burling Wealth Partners Chicago, Illinois $618M AUM 17.33% 1-Year Est. Return
MC
McMorgan & Co San Francisco, California $618M AUM 8.76% 1-Year Est. Return

Chad R. Baker's Q2 2018 Portfolio in Review

As of Q2 2018, Chad R. Baker held 61 positions worth $250M, down 1.3% from $253M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Chad R. Baker withdrew a net $9.77M in Q2 2018, closing 6 positions and reducing 7 holdings. Its most notable exit was CVS Health, an estimated $2.97M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.

Against the trend, Chad R. Baker opened a new position in Teladoc Health worth $2.69M.

  • Chad R. Baker's largest Q2 2018 buy was Teladoc Health: 46,345 shares worth $2.69M.
  • Chad R. Baker added most to Xilinx Inc in Q2 2018, an estimated $1.81M increase.
  • Chad R. Baker's biggest Q2 2018 reduction was Procter & Gamble, cutting an estimated $2.53M.
  • Chad R. Baker fully exited CVS Health in Q2 2018, selling an estimated $2.97M.
  • Chad R. Baker's ten largest holdings make up 39% of its $250M portfolio in Q2 2018.
  • Chad R. Baker opened 2 new positions and closed 6 in Q2 2018.
  • Chad R. Baker's portfolio value fell 1.3% quarter-over-quarter to $250M.

Based on Chad R. Baker's 13F filing for Q2 2018, filed 13 Aug 2018.